- Home
- GYRO vs ALUR Comparison
GYRO vs ALUR Comparison
Compare GYRO & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRO
- ALUR
- Stock Information
- Founded
- GYRO 1946
- ALUR 2009
- Country
- GYRO United States
- ALUR United States
- Employees
- GYRO N/A
- ALUR N/A
- Industry
- GYRO Building operators
- ALUR
- Sector
- GYRO Real Estate
- ALUR
- Exchange
- GYRO Nasdaq
- ALUR Nasdaq
- Market Cap
- GYRO 19.3M
- ALUR 19.1M
- IPO Year
- GYRO N/A
- ALUR N/A
- Fundamental
- Price
- GYRO $8.10
- ALUR $3.35
- Analyst Decision
- GYRO
- ALUR Strong Buy
- Analyst Count
- GYRO 0
- ALUR 3
- Target Price
- GYRO N/A
- ALUR $22.83
- AVG Volume (30 Days)
- GYRO 818.0
- ALUR 4.1M
- Earning Date
- GYRO 01-01-0001
- ALUR 03-26-2025
- Dividend Yield
- GYRO N/A
- ALUR N/A
- EPS Growth
- GYRO N/A
- ALUR N/A
- EPS
- GYRO N/A
- ALUR N/A
- Revenue
- GYRO $2,738,019.00
- ALUR $32,110,000.00
- Revenue This Year
- GYRO N/A
- ALUR $2.18
- Revenue Next Year
- GYRO N/A
- ALUR $35.85
- P/E Ratio
- GYRO N/A
- ALUR N/A
- Revenue Growth
- GYRO N/A
- ALUR N/A
- 52 Week Low
- GYRO $7.65
- ALUR $2.15
- 52 Week High
- GYRO $11.96
- ALUR $98.75
- Technical
- Relative Strength Index (RSI)
- GYRO 24.74
- ALUR 51.19
- Support Level
- GYRO $8.13
- ALUR $2.72
- Resistance Level
- GYRO $8.55
- ALUR $3.50
- Average True Range (ATR)
- GYRO 0.11
- ALUR 0.40
- MACD
- GYRO -0.00
- ALUR 0.18
- Stochastic Oscillator
- GYRO 0.00
- ALUR 56.99
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.